Chinese artificial intelligence startup DeepSeek has reportedly established two private limited companies in Hong Kong after its AI Assistant became one of the top three free applications available on Apple's App Store in the United States, according to mainland media Cailianpress.

The two companies – Deepseek Limited and Deepseek (HK) Limited – were officially registered in Hong Kong on February 5, Cailianpress reported, citing Qichacha’s information.

The tech firm has also successfully registered several trademarks for the DeepSeek brand, with international classifications that include social law, design research, and scientific instruments, the report said.

Meanwhile, DeepSeek’s data shows, that just 20 days after its launch, it has amassed 20 million daily active users, making it the fastest-growing company globally in terms of DAU.

What Is a First World (aka Developed or Industrialized) Country?

What Is a First World (aka Developed or Industrialized) Country?

Halloween's Effect on the Economy

Halloween's Effect on the Economy

Command Economy: Advantages and Disadvantages

Command Economy: Advantages and Disadvantages

Fed’s Preferred Inflation Gauge Rose More Than Expected in August 2022

Fed’s Preferred Inflation Gauge Rose More Than Expected in August 2022

U.S. Federal Government Tax Revenue by Year

U.S. Federal Government Tax Revenue by Year

Sarbanes-Oxley Summary

Sarbanes-Oxley Summary

Eggspensive? Yes. Eggflation? Not a Chance

Eggspensive? Yes. Eggflation? Not a Chance

China faces up to 0.4 ppt hit in GDP from tariffs

China faces up to 0.4 ppt hit in GDP from tariffs

Minimal exposure for Hutchison if its Panama operations canceled

Minimal exposure for Hutchison if its Panama operations canceled

US stocks close higher on resurgent AI optimism

US stocks close higher on resurgent AI optimism

Gradual decline in construction of new private homes predicted

Gradual decline in construction of new private homes predicted

China's health regulator defends quality of local generic drugs

China's health regulator defends quality of local generic drugs